Sana, a Japanese member of the group TWICE, told her difficulties in living in Korea.Jihyo and Sana appeared on SBS 'Whenever ...

TWICE Sana confesses to the past when she almost gave up her debut. TWICE Ji-hyo and Sana will appear on SBS 'Whenever You ...

South Korean girl group TWICE has been slammed by netizens for copying BLACKPINK member Jennie's recently release solo track ...

"There was something hauntingly beautiful about them," Sana Pierre told Newsweek after receiving a bouquet on her birthday.

Alice Gibbs is a Newsweek Senior Internet Trends & Culture Reporter based in the U.K. For the last two years she has specialized in viral trends and internet news, with a particular focus on ...

PHOENIX (AP) — Jordan Beck hit two homers and a triple, driving in three runs and scoring four to rally the Colorado Rockies from a five-run deficit to a 14-12 victory over the Arizona ...

Cisco is now getting lots of attention from Wall Street as the narrative of AI-induced demand gains momentum. Although the management is making the right moves in the long run, the share price ...

It’s a simple way to start your day with something that supports stamina, focus, and general wellness—without needing anything fancy. If you like making your own snacks, spirulina is easy to use.

LINCOLN, Neb. (KOLN) - For the second evening in a row, customers and staff at Red Robin near 27th Street and Pine Lake Road had to clear the building. For Lincoln Fire and Rescue, it was another ...

There were fans arriving here joking that trips to Latvia on a Thursday night are overrated anyway – their attempt at coping with Crystal Palace’s FA Cup triumph meaning finishing eighth will ...

The beautiful weather didn't stop participants from donning a fancy dress costume or too. From dinosaurs and bees to wizards, Disney princesses and a Teenage Mutant Ninja Turtle or two ...

Current biologics have to be given every two or four weeks, so a drug that can be given just twice a year would be a step up in patient convenience The SWIFT-1 and SWIFT-2 trials compared ...